###begin article-title 0
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 102 106 <span type="species:ncbi:10090">Mice</span>
Pol II-Expressed shRNA Knocks Down Sod2 Gene Expression and Causes Phenotypes of the Gene Knockout in Mice
###end article-title 0
###begin p 1
###xml 942 946 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 316 331 <span type="species:ncbi:10090">transgenic mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 807 812 <span type="species:ncbi:9606">human</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
###xml 1501 1505 <span type="species:ncbi:10090">mice</span>
RNA interference (RNAi) has been used increasingly for reverse genetics in invertebrates and mammalian cells, and has the potential to become an alternative to gene knockout technology in mammals. Thus far, only RNA polymerase III (Pol III)-expressed short hairpin RNA (shRNA) has been used to make shRNA-expressing transgenic mice. However, widespread knockdown and induction of phenotypes of gene knockout in postnatal mice have not been demonstrated. Previous studies have shown that Pol II synthesizes micro RNAs (miRNAs)-the endogenous shRNAs that carry out gene silencing function. To achieve efficient gene knockdown in mammals and to generate phenotypes of gene knockout, we designed a construct in which a Pol II (ubiquitin C) promoter drove the expression of an shRNA with a structure that mimics human miRNA miR-30a. Two transgenic lines showed widespread and sustained shRNA expression, and efficient knockdown of the target gene Sod2. These mice were viable but with phenotypes of SOD2 deficiency. Bigenic heterozygous mice generated by crossing these two lines showed nearly undetectable target gene expression and phenotypes consistent with the target gene knockout, including slow growth, fatty liver, dilated cardiomyopathy, and premature death. This approach opens the door of RNAi to a wide array of well-established Pol II transgenic strategies and offers a technically simpler, cheaper, and quicker alternative to gene knockout by homologous recombination for reverse genetics in mice and other mammalian species.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 930 934 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 862 877 <span type="species:ncbi:10090">transgenic mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
Reverse genetics studies gene functions by altering a gene and observing the consequences. A powerful method of reverse genetics in mammals is gene knockout by homologous recombination, which mutates a gene to prevent its functional expression. Using this method, investigators have revealed the functions of many genes. However, this method is relatively complex, time-consuming, and costly. In addition, this method is limited to studies in mice because it is not well established in other mammalian species. The authors of this study tested an alternative method using RNA interference (RNAi), which is a widely conserved mechanism in eukaryotes and can mediate gene-specific silencing. These investigators used RNA polymerase II (Pol II) to express a short hairpin RNA (shRNA) that triggers destruction of the mRNA-encoding Mn superoxide dismutase (SOD2) in transgenic mice. These mice exhibit phenotypes that were typical in Sod2 knockout mice, including elevated levels of oxidative stress in various tissues, fat deposition in liver and muscles, dilated cardiomyopathy, and premature death. These results open the door of RNAi to a wide array of well-established Pol II transgenic strategies and offer a technically simpler, cheaper, and quicker alternative to gene knockout for reverse genetics in mice and other mammalian species.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b001">1</xref>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b001">1</xref>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b002">2</xref>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
Gene knockout by homologous recombination has been instrumental in investigating gene functions in mammals. It has been used to reveal gene functions in normal as well as in pathogenic pathways in vivo, and to generate models for many genetic disorders. However, the technical complexity, lengthy process, and high cost have limited its broad application. This is particularly problematic considering the fact that of the ~30,000 currently known mouse genes, only 10% have been knocked out, and even fewer are readily accessible by the research community [1]. Furthermore, the knockout technology, in most instances, generates animals with ~50% or 0% expression of the target gene, and it is difficult to create graded hypomorphic models, which may be necessary for modeling some diseases. In addition, the knockout technology is not well established in other mammalian species, consequently limiting the investigation of gene functions and the development of disease models in other mammalian species. These limitations may be overcome by RNA interference (RNAi) technology [1,2].
###end p 5
###begin p 6
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b003">3</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b004">4</xref>
###xml 278 288 278 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1080 1081 1080 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b005">5</xref>
###xml 278 288 <span type="species:ncbi:7227">Drosophila</span>
RNAi is a widely conserved mechanism in eukaryotes [3]. Triggered by double-stranded RNA (dsRNA) in cells, RNAi destroys the target RNA that shares sequence homology with the dsRNA [4]. The mechanism of RNAi is not fully understood. A simplified model based mainly on data from Drosophila has the following steps: First, Dicer, an enzyme of the RNase III family, initiates ATP-dependent fragmentation of long dsRNA into 21- to 25-nucleotide double-stranded fragments, called small interfering RNAs (siRNAs). Second, the siRNA duplexes bind the proteins Dicer and R2D2, which facilitate the formation of a siRNA/multiprotein complex called RNA-induced silencing complex (RISC) loading complex. Third, the siRNA duplex in the RISC loading complex unwinds to form an active RISC that contains a single-stranded RNA (called the guide strand). Fourth, the RISC recognizes the target RNA by Watson-Crick base pairing with the guide strand and cleaves the target RNA. Finally, the RISC releases its cleaved product and goes on to catalyze a new cycle of target recognition and cleavage [5].
###end p 6
###begin p 7
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b006">6</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b007">7</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b008">8</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b009">9</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b010">10</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b011">11</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b012">12</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b014">14</xref>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b015">15</xref>
In differentiated mammalian cells, long dsRNA activates RNA-dependent protein kinase PKR and type I interferon response, which leads to a nonspecific global translation depression and apoptosis [6]. However, this nonspecific reaction can be circumvented by introduction of synthetic siRNA [7,8], which can go into the RNAi pathway much like the siRNAs produced from long dsRNA can. Alternatively, RNAi may be triggered by a short hairpin RNA (shRNA) synthesized from gene constructs with RNA polymerase III (Pol III) or Pol II promoters [9]. The Pol III-synthesized shRNA is exported by exportin 5 from the nucleus to the cytoplasm [10,11], where it is processed by Dicer to generate siRNA, which goes into the RNAi pathway and mediates gene silencing. The Pol II-expressed shRNA mimics micro RNAs (miRNAs) and has one additional step of processing before nuclear export: it is synthesized as a long Pol II transcript [12,13] and is processed by the microprocessor complex that contains Drosha and Pasha to produce the shRNA [14,15].
###end p 7
###begin p 8
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b016">16</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b017">17</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
The simplicity and specificity of RNAi has made RNAi a routine tool for investigation of gene functions in invertebrates and mammalian cells. Attempts have also been made to develop RNAi as an in vivo reverse genetics tool in mice. An early experiment directly injected long dsRNA into mouse embryonic stem cells. Successful knockdown and the phenotype of the gene deletion were observed in embryogenesis [16]. This approach can produce only transient inhibition of target gene expression. Another experiment used an oocyte-specific promoter to express a long hairpin (~500 bp) against c-Mos and demonstrated the expected phenotypes in oogenesis [17]. Both approaches cannot be applied widely because of the toxicity associated with long dsRNA in differentiated somatic cells.
###end p 8
###begin p 9
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b018">18</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b023">23</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b018">18</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b019">19</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b024">24</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b026">26</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b022">22</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b027">27</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b028">28</xref>
###xml 92 107 <span type="species:ncbi:10090">transgenic mice</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 513 518 <span type="species:ncbi:10090">mouse</span>
With the advent of Pol III promoter-directed synthesis of shRNAs, several groups engineered transgenic mice using Pol III-shRNA constructs [18-23]. In all cases, knockdown of the marker transgene GFP in neonates was reported. In two cases, phenotypes resembling genetic knockouts were observed in developing mouse embryos [18] and hematopoietic stem cells [19]. Recently, Cre-lox-inducible Pol III promoters have been demonstrated to knock down target genes and induce phenotypes of gene deficiency in developing mouse embryos [24-26]. However, the success rate of gene knockdown and phenotypic expression is low using Pol III constructs [22,27]; despite the improvements using approaches employing targeted insertion in embryonic stem cells and tetraploid blastocyst complementation [28], widespread knockdown and phenotypes of gene deletion that develop in postnatal animals have not been demonstrated.
###end p 9
###begin p 10
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b029">29</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b030">30</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b024">24</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b026">26</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b031">31</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b032">32</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b034">34</xref>
###xml 470 485 <span type="species:ncbi:10090">transgenic mice</span>
###xml 582 587 <span type="species:ncbi:10090">mouse</span>
In addition to Pol III, Pol II can also direct shRNA synthesis [29,30] and mediate efficient silencing in cultured cells [13]. Compared with Pol III promoters, Pol II promoter-directed synthesis of shRNAs can be advantageous for transgenic RNAi. Although limited choices of Pol III promoters have been developed to express shRNA, a large repertoire of Pol II promoters, including temporally and spatially specific and inducible promoters, have been successfully used in transgenic mice. In addition, the current Pol III strategies rely on the availability of various Cre transgenic mouse lines for shRNA induction [24-26]. These Cre transgenic lines do not exist in other mammalian species. Therefore, the application of this Pol III strategy in other mammalian species is currently impractical. Recent evidence indicates that miRNAs, the endogenous form of shRNAs, are downstream of Pol II promoters [31] and are expressed by Pol II activity [32-34]. Therefore, strategies using Pol II-directed synthesis of shRNA mimic the natural miRNA synthesis and could be an efficient RNAi strategy in vivo.
###end p 10
###begin p 11
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Sod2)</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b035">35</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b037">37</xref>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 157 172 <span type="species:ncbi:10090">transgenic mice</span>
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 680 685 <span type="species:ncbi:10090">mouse</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
To test this idea, we used a construct that is composed of a human ubiquitin C promoter and an shRNA with the human miRNA miR-30a structure [13] to generate transgenic mice. We targeted the shRNA against the mouse Mn superoxide dismutase (Sod2) gene, because Sod2-null mice generated by standard knockout technology have striking postnatal phenotypes that have been well characterized [35-37]. This Pol II strategy expressed siRNA widely in different tissues, knocked down the Sod2 gene expression, and induced SOD2-hypomorphic phenotype. In addition, bigenic heterozygous mice generated by crossing the two independent transgenic lines showed phenotypes typical of the SOD2-null mouse, including slow growth, fatty liver, dilated cardiomyopathy, and premature death. Thus, this Pol II RNAi strategy can be an alternative to gene knockout technology and opens the door of RNAi to a wide array of Pol II transgenic strategies to investigate gene functions in mice and other mammalian species.
###end p 11
###begin title 12
Results/Discussion
###end title 12
###begin p 13
###xml 31 39 31 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figure 1</xref>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 499 507 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figure 1</xref>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figures 1</xref>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">1</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg001">S1</xref>
###xml 895 904 895 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg002">Figure S2</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
###xml 385 400 <span type="species:ncbi:10090">transgenic mice</span>
The construct UbC-SOD2hp-EGFP (Figure 1; also see [13]) consists of the human ubiquitin C promoter, an shRNA-coding hairpin placed in the first intron, followed by the enhanced green fluorescent protein (EGFP) coding sequence and a poly-adenylation signal. The shRNA-coding hairpin mimics human microRNA miR-30a structure and target mouse Sod2 mRNA. Using this construct, we generated transgenic mice by pronuclear injection of fertilized eggs. Screening of 62 founders yielded five positive lines (Figure 1A). Northern blots showed that two of the five lines (lines 8 and 26) expressed siRNA broadly (Figures 1B, 1C, and S1A) and this expression was stable over multiple generations and during aging (the same level of expression was observed in animals from 40 to 200 d old; unpublished data). By real-time PCR line 8 carried a single copy of the transgene while line 26 carried three copies (Figure S2). The transgene copy number did not predict the level of siRNA levels since line 8 had a higher level of siRNA than line 26 (see below).
###end p 13
###begin p 14
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 403 412 403 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figures 1</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg001">S1</xref>
###xml 430 439 430 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figures 1</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg001">S1</xref>
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g001">Figure 1</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b034">34</xref>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b014">14</xref>
###xml 1541 1550 1541 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg003">Figure S3</xref>
###xml 1667 1676 1667 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg003">Figure S3</xref>
###xml 1682 1684 1682 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg003">S3</xref>
###xml 1725 1734 1725 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg003">Figure S3</xref>
###xml 1740 1742 1740 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0020010-sg003">S3</xref>
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1393 1408 <span type="species:ncbi:10090">transgenic mice</span>
The pattern of expression in transgenic mice differed from the pattern in cultured cells in two regards: none of these transgenic lines expressed detectable EGFP and shRNA (only siRNA was detected). This contrasts with what we observed in cultured cells, in which both were detectable [13]. Nevertheless, the siRNA knocked down the abundance of SOD2 as indicated by the decreased levels of the protein (Figures 1D and S1B), mRNA (Figures 1E and S1C), and enzyme activity (Figure 1F). The rapid processing of pre-miRNA in vivo probably caused the lack of shRNA detection. This explanation is consistent with the lack of pre-miRNA detection for other endogenous miRNAs in mammalian cells [34]. The lack of EGFP was puzzling. One possibility was that the transgene was altered. This was ruled out by sequencing the transgene extracted by PCR, which revealed no alteration in the transgene structure. Another possibility was that the pri-miRNA processing in vivo was highly efficient, so that the processing of pri-miRNA occurred before the splicing, and, consequently, the mRNA could not be properly spliced and exported to the cytoplasm for EGFP expression. The processing of pri-miRNA involves Drosha [14]. Therefore, if our hypothesis was correct, inhibition of Drosha expression should lead to EGFP expression. To test this, we transduced fibroblasts isolated from the skeletal muscle of the transgenic mice using a recombinant adenovirus that expresses an shRNA against Drosha. By RT-PCR the Drosha mRNA levels were substantially reduced (Figure S3A), indicating the effectiveness of the shRNA. While the nontransduced cells showed no detectable EGFP fluorescence (Figure S3B and S3C), the transduced cells expressed EGFP (Figure S3D and S3E). This result supports our hypothesis.
###end p 14
###begin p 15
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b037">37</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b038">38</xref>
###xml 451 459 451 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">2</xref>
###xml 660 668 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 1016 1024 1016 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 1095 1103 1095 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 1272 1276 1272 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 1382 1390 1382 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 1460 1468 1460 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
To confirm the knockdown of Sod2 gene expression, we examined the in vivo consequence of SOD2 deficiency. First, we compared the activity of the mitochondrial enzyme succinate dehydrogenase (SDH) between the transgenic and wild-type animals, because SOD2 knockout is known to cause a decrease in SDH activity [37,38]. We stained tissue sections from the heart using histochemical staining, and observed a decrease in the staining intensity in line 8 (Figure 2A and 2B). Second, we isolated fibroblasts from skeletal muscle and measured the levels of superoxide in these cells. We observed that the superoxide levels were increased in the two transgenic lines (Figure 2C). This increase was higher in line 8 than in line 26, and, therefore, was correlated with the degree of SOD2 knockdown (see below). Third, we tested the sensitivity of the fibroblasts to oxidative stress induced by t-butylhydroperoxide (t-BuOOH) treatment. Fibroblasts from transgenic line 8 showed a higher sensitivity than the wild-type cells (Figure 2D), consistent with the lowered levels of SOD2 protein in these cells (Figure 2E). To ensure that the enhanced sensitivity was caused by the knockdown of SOD2 expression, we transduced the fibroblasts with a recombinant adenovirus that expressed a Sod2 gene whose mRNA was resistant to the siRNA expressed by the transgene. Expression of this SOD2 molecule (Figure 2E) rescued the cells from their hypersensitivity to oxidative stress (Figure 2D).
###end p 15
###begin p 16
###xml 128 143 <span type="species:ncbi:10090">transgenic mice</span>
###xml 629 644 <span type="species:ncbi:10090">transgenic mice</span>
Based on these data, we conclude that ubiquitin C promoter-directed shRNA synthesis effectively silenced the target molecule in transgenic mice. Despite this significant knockdown (by 60%-90%) in all the tissues examined and the evidence of functional SOD2 deficiency, the two transgenic lines were viable to 400 d (observed to date). SOD2-null phenotypes, including small body size, dilated cardiomyopathy, lipid deposition in liver and heart, and premature death, were not observed. To determine whether knockout phenotypes could be generated, we crossed the two lines that expressed the siRNA to generate bigenic heterozygous transgenic mice. We took this approach because it was advantageous compared with generating homozygous animals of each lines, the phenotype of which could be complicated by the potential gene disruption at the transgene insertion site.
###end p 16
###begin p 17
###xml 105 113 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g003">Figure 3</xref>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g003">Figure 3</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g003">3</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b035">35</xref>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">Figure 4</xref>
###xml 511 519 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">Figure 4</xref>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">Figure 4</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">4</xref>
###xml 604 612 604 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">Figure 4</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g004">4</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
The line 8/26 bigenic mice expressed a higher level of siRNA than either of the singly transgenic lines (Figure 3A), leading to knockdown of SOD2 protein and mRNA to nearly undetectable levels (Figure 3B and 3C). These mice exhibited phenotypes similar to the previously reported SOD2 knockout mice [35], including smaller body size than the wild-type littermates (Figure 4A) and death within 20 d after birth (in 34 bigenic animals that we obtained so far). In addition, they developed dilated cardiomyopathy (Figure 4B) and had increased lipid deposition in the heart (Figure 4C and 4D) and the liver (Figure 4E and 4F).
###end p 17
###begin p 18
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b039">39</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b041">41</xref>
###xml 372 379 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(OSA1),</italic>
###xml 435 442 435 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(STAT1)</italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b040">40</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b041">41</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OSA1</italic>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g005">Figure 5</xref>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 686 701 <span type="species:ncbi:10090">transgenic mice</span>
Several studies have shown that some shRNA or siRNA could trigger interferon response [39-41]. This raises the possibility that interferon response might be responsible for the phenotype observed in these mice. To test this, we examined the levels of two genes known to be dramatically induced by the dsRNA-triggered interferon response, 2',5'-oligoadenylate synthetase 1 (OSA1), and signal transducer and activator of transcription 1 (STAT1) [40,41]. Real-time PCR analysis of the mRNA of OSA1 and STAT1 failed to detect changes in the expression levels of these two genes in the heart, spleen, and liver in the transgenic line 8 (Figure 5), indicating no interferon response in these transgenic mice.
###end p 18
###begin p 19
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</italic>
###xml 195 210 <span type="species:ncbi:10090">transgenic mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 661 676 <span type="species:ncbi:10090">transgenic mice</span>
Taken together, the phenotypes are likely caused by the specific effect of SOD2 knockdown because (1) the siRNA was expressed widely; (2) the consequences of SOD2 deficiency were observed in the transgenic mice; (3) in cells isolated from these mice the hypersensitivity to oxidative stress was corrected by the Sod2 gene that was resistant to the siRNA; (4) the phenotype typical of the SOD2-null mouse was observed when siRNA levels were increased in the bigenic 8/26 mice; and (5) levels of OSA1 and STAT1, two molecules involved in the dsRNA-induced interferon response, were unchanged. These results demonstrate that Pol II-mediated expression of shRNA in transgenic mice can be used to investigate gene functions in mammals.
###end p 19
###begin p 20
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b042">42</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b029">29</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b030">30</xref>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b043">43</xref>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b044">44</xref>
###xml 1575 1577 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b045">45</xref>
###xml 1597 1599 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b046">46</xref>
###xml 1600 1602 1600 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b047">47</xref>
###xml 1829 1831 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b024">24</xref>
###xml 1832 1834 1832 1834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b026">26</xref>
###xml 780 795 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1257 1272 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1314 1329 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1816 1821 <span type="species:ncbi:10090">mouse</span>
Thus, the Pol II-directed synthesis of shRNA can be an alternative to gene knockout technology for reverse genetics in mammals. Although gene knockout remains a useful approach for the complete gene deletion or gene modification, our RNAi approach can achieve near knockout conditions and is economical in cost and time. In addition, the construct design is simple and in principle not different from the standard transgene design for gene overexpression. The placement of the shRNA-encoding hairpin is flexible: it can be placed in introns or in the 3' untranslated regions [13,42], and the shRNA-encoding transcript is not required to encode a protein [13,29,30]. Therefore, a wide variety of transgene promoters that have already been successfully used to overexpress genes in transgenic mice can be readily adapted for suppressing the genes. When spatially and temporally specific promoters are used, controlled suppression of the target gene can be achieved. Furthermore, this approach provides a more flexible system to model hypomorphic allele function. While the standard knockout technology reduces the target gene expression to 50% or 0% in most instances, transgenic RNAi can reduce the target gene to more variable degrees in different lines of transgenic mice or by induction using small molecules in transgenic mice made with inducible Pol II promoters [43,44]. The simplicity of this approach can accelerate the generation of models for diseases that are caused by various degrees of genetic hypomorphism, such as autosomal dominant polycystic kidney disease [45], various cancers [46,47], and other diseases. Finally, gene knockout by homologous recombination has not been established in other mammalian species. Current Pol III strategies rely on the crosses with numerous Cre-expression transgenic mouse lines [24-26], which are not available in other mammalian species. Our knockdown strategy can overcome these limitations and be used to carry out reverse genetics and to generate disease models in other mammalian species.
###end p 20
###begin title 21
Materials and Methods
###end title 21
###begin title 22
###xml 29 44 <span type="species:ncbi:10090">transgenic mice</span>
Generation of SOD2 knockdown transgenic mice.
###end title 22
###begin p 23
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 180 195 <span type="species:ncbi:10090">transgenic mice</span>
###xml 634 649 <span type="species:ncbi:10090">transgenic mice</span>
###xml 706 721 <span type="species:ncbi:10090">transgenic mice</span>
The transgene construct that contains the hairpin targeting the Sod2 gene under the control of human ubiquitin C promoter (UbC-SOD2hp-EGFP) has been described previously [13]. The transgenic mice were made by pronuclear injection of the linearized construct into the fertilized eggs, which were generated from crossings of C57BL/6 and SJL. Positive founders and offspring carrying the transgene were identified by PCR of the tail DNA using the primers 5'-CGCCCTCGTCGTGTCGTGA-3' (forward) and 5'-CGGCGCGGGTCTTGTAGTTGC-3' (reverse). The transgenic lines were maintained by crossing founders to C57BL/6. To generate bigenic heterozygous transgenic mice, two shRNA-expressing lines were crossed and the doubly transgenic mice were identified by quantitative real-time PCR of tail DNA.
###end p 23
###begin title 24
Northern blot.
###end title 24
###begin p 25
###xml 483 485 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 576 580 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 612 614 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 666 668 660 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 184 189 <span type="species:ncbi:10090">mouse</span>
###xml 570 575 <span type="species:ncbi:10090">mouse</span>
###xml 758 763 <span type="species:ncbi:10090">mouse</span>
Mice were decapitated under anesthesia, and various tissues were quickly dissected, snap-frozen in liquid nitrogen, and stored at -80 degreesC. The total RNA was extracted from frozen mouse tissues using Trizol (Sigma, St Louis, Missouri, United States). Thirty micrograms of total RNA was fractionated on 15% polyacrylamide gels and transferred onto Hybond TM-N+ membrane (Amersham Biosciences, Little Chalfont, United Kingdom). After UV cross-linking, the membrane was probed with 32P-labeled synthetic RNA oligonucleotide complementary to the antisense strand of the mouse Sod2 shRNA as described previously [13]. For some blots, the membranes were reprobed with 32P-labeled synthetic DNA oligonucleotide (5'-ACGAATTTGCGTGTCATCCTTGCG-3') complementary to mouse U6 RNA.
###end p 25
###begin title 26
Western blot.
###end title 26
###begin p 27
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 102 103 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 701 707 <span type="species:ncbi:9986">rabbit</span>
###xml 822 827 <span type="species:ncbi:10090">mouse</span>
The frozen mouse tissues were homogenized in ice-cold lysis buffer containing 0.4% NP-40, 0.2 mM Na3VO4, 20 mM HEPES (pH 7.9), and a cocktail of protease inhibitors (Complete-Mini; Sigma). The protein content in the cleared lysate was determined using the BCA assay. Equal amount of total proteins from transgenic and wild-type control animals was resolved by 15% SDS-PAGE and blotted onto GeneScreen Plus membrane (PerkinElmer, Wellesley, Massachusetts, United States). Proteins were detected using specific primary antibodies and the SuperSignal kit (Pierce Biotechnology, Rockford, Illinois, United States) and photographed using the Kodak Digital Image Station 440CF. The primary antibodies were: rabbit anti-Mn superoxide dismutase (SOD2; 1:1,000, Stressgen Biotechnologies, San Diego, California, United States) and mouse anti-glyceraldehye-3-phosphate dehydrogenase (GAPDH; 1:10,000; Abcam, Cambridge, United Kingdom). After detection of SOD2, the membrane was stripped for 30 min at 55 degreesC in a buffer containing 100 mM beta-mercaptoethanol, 2% SDS (w/v), and 62.5 mM Tris-HCl (pH 6.7), and used again for detection of GAPDH immunoreactivity, which served as loading control.
###end p 27
###begin title 28
Real-time quantitative RT-PCR.
###end title 28
###begin p 29
###xml 1499 1503 1475 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 1559 1564 1535 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1609 1613 1585 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 1674 1678 1650 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
Total RNA isolated using the TRI reagent was further purified with the RNeasy kit (Qiagen, Valencia, California, United States) and subjected to digestion on column with RNase-Free DNase (Qiagen). One microgram of purified total RNA from each sample was reversely transcribed to cDNA with oligo-dT primer using the RT kit (Invitrogen, Carlsbad, California, United States). The cDNA was used for quantitative PCR with SYBR green kit (Qiagen) according to manufacturer's instruction. The primer concentration was 500 nM. Cycling conditions were 15 min at 95 degreesC (to activate the hot-start Taq polymerase supplied with the SYBR Green detection kit), followed by 40 cycles of 15 s at 94 degreesC, 30 s at 60 degreesC, and 20 s at 72 degreesC. During amplification the fluorescence signal, which is proportional to the amount of dsDNA produced, was monitored. A complete amplification profile for each of the 96 wells of a PCR plate was obtained, which was used for the analysis. At the end of the PCR run, melting curves of the amplified products were obtained, which were used to determine the specificity of the amplification reaction. In pilot experiments, aliquots of the amplified products were separated on 3% agarose gels to ensure amplification of specific products of the predicted length. The amplification curves were used to calculate the threshold cycle number at which the amplification curve reaches the beginning of the linear phase of amplification. The threshold cycle number for Sod2 gene was normalized to those of the housekeeping genes GAPDH and ribosomal RNA L17. The knockdown of the Sod2 expression was determined by calculating the fold change of Sod2 in transgenic tissues relative to the wild-type tissues.
###end p 29
###begin title 30
SOD2 activity.
###end title 30
###begin p 31
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b048">48</xref>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 605 606 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 608 609 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 620 621 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 624 625 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
SOD2 activity was determined by inhibition of xanthine/xanthine oxidase-induced cytochrome C reduction [48]. Frozen tissues were homogenized in 10 volumes of ice-cold buffer (10 mM KH2PO4 [pH 7.4], 20 mM EDTA, 30 mM KCl). The supernatant was collected after centrifugation of homogenates in a desktop microcentrifuge for 15 min at 4 degreesC and measured for protein concentration using BAC assay (Pierce). The activity of SOD1 was inactivated by treating the lysates with 5 mM KCN before SOD2 activity assay. To a cuvette, 967 mul of solution A (50 muM xanthine, 20 muM acetylated cytochrome C, 25 muM KH2PO4, 25 muM Na2HPO4, and 0.1 mM EDTA) was added, followed by 16.7 mul of the treated lysates and 16.7 mul of solution B (0.2 U/ml xanthine oxidase in 0.1 mM EDTA). The absorbance at 550 nm was read at 1-min intervals for 10 min. SOD2 activity in knockdown lysates was determined by comparing with an SOD2 standard curve (SOD2 enzyme; Sigma) and expressed relative to that in the wild-type lysates.
###end p 31
###begin title 32
SDH histochemistry.
###end title 32
###begin p 33
###xml 210 212 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b038">38</xref>
Immediately following death, tissues were harvested and frozen on dry ice and sectioned at 20 mum thickness at -25 degreesC. SDH staining was performed and evaluated as previously described on frozen sections [38].
###end p 33
###begin title 34
Evaluation of ROS levels and tolerance to oxidative stress in fibroblasts.
###end title 34
###begin p 35
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b049">49</xref>
###xml 532 533 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 787 791 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 1340 1344 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 1344 1347 1325 1328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1546 1547 1527 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 2108 2109 2083 2084 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2167 2171 2142 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:9913">calf</span>
###xml 1348 1353 <span type="species:ncbi:10090">mouse</span>
Fibroblasts were isolated from skeletal muscle in 15-d-old mice using the method modified from Crisona et al. [49]. Skeletal muscles were removed from hindlimbs and minced in Hank's balanced salt solution. The muscle slurry was digested with collagenase type I (0.5% in Hank's balanced salt solution; Invitrogen) at 37 degreesC for 1 h. The cells were pelleted by centrifugation and subjected to further digestion with trypsin at 37 degreesC for 1 h. After another round of centrifugation and washing, the cells were plated to 75-cm2 flasks and grown in DMEM supplemented with 10% FBS, 100 mg/ml streptomycin, and 100 U/ml penicillin. The cultured cells were split every 3 d and used before four passages. For determination of ROS (superoxide), 500,000 primary (passage 2) wild-type and Sod2 shRNA transgenic skeletal muscle fibroblasts were incubated in DMEM media containing 10% fetal calf serum, antibiotics, and 2 muM dihydroethidine (Molecular Probes, Eugene, Oregon, United States) for 30 min at 37 degreesC in the dark. After incubation, the cells were centrifuged, resuspended in freshly prepared cold FACS staining buffer (PBS, 1% BSA), and the FL-2 fluorescence of 20,000 cells per sample was analyzed using a Becton Dickinson LSR cytometer (Palo Alto, California, United States). In the same experiments, passage-1 wild-type and Sod2-/- mouse embryonic fibroblasts were included as controls. To prevent bias, the ROS determination was performed in a blind fashion. For viability assay, the cells were plated to 96-well plates at 1 x 104 cells per well and allowed to attach overnight at 37 degreesC. On the following day, the cells were treated with t-BuOOH at different concentrations for 2 h. After three washes with PBS, the cells were grown in DMEM containing 10% FBS and MTS reagent (Promega, Madison, Wisconsin, United States) for 2 h. To measure the viability, the absorbance of cultures was read at 495 nm with a plate reader and normalized to the average absorbance of the cells untreated with tBuOOH. For the rescue experiments, the transgenic cells (two passages) were infected in 25-cm2 flasks with adenoviral vectors expressing RNAi-resistant Sod2 gene (see below). After 3 d, the transduced cells were split into 96-well plates, grown for 24 h, and treated with t-BuOOH; the viability was measured as described above. Statistical analysis was performed using ANOVA followed by Tukey post-hoc test to compare group means.
###end p 35
###begin title 36
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2.</italic>
Adenoviral vector expressing RNAi-resistant Sod2.
###end title 36
###begin p 37
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 291 292 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 295 296 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 866 867 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 354 357 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
ViraPower adenoviral kit (Invitrogen) was used. An RNAi-resistant Sod2 gene was generated by introducing four silent mutations within shRNA target region. The target sequence of SOD2 mRNA was 5'-AAGGGAGATGTTACAACT-3', and the target sequence of RNAi-resistant SOD2 mRNA was 5'-AAG GGT GAC GTA ACT ACT-3' (bold letters indicate the silent mutations). The CMV-SOD2 expression cassette was introduced into ViraPower adenoviral vector (RAd; Invitrogen) using the Gateway method. The RAd-SOD2 vector was transiently transfected into a RAd producer cell line 293A that stably expresses E1 proteins required for production of adenovirus. The RAd-SOD2 was harvested from transiently transfected 293A cells and amplified by infecting fresh 293A cells. The virus was purified by CsCl gradient centrifugation, dialyzed against a buffer containing 10 mM Tris (pH 7.5), 1 mM MgCl2, and 10% glycerol, and stored in aliquots at -80 degreesC. The viral titer (plaque-forming unit) was determined using 293A cells according to the manufacturer's instructions. To transduce fibroblast cells, the virus was used at a multiplicity of infection (MOI; 50) and incubated with the culture for 3 h before the media were changed. The transduced cells were used for viability assay at 48 h after transduction.
###end p 37
###begin title 38
Oil Red O staining.
###end title 38
###begin p 39
Oil Red O staining was performed on frozen sections. The fresh tissues collected as described above were frozen in powdered dry ice. The frozen sections (12 mum) were cut using a Cryostat and stained with Oil Red O solution on slides as follows: the sections were fixed in 10% formalin for 5 min, washed with several changes of phosphate-buffered saline, stained in prewarmed Oil Red O solution (60 degreesC; Sigma) for 8 min, washed again several times with distilled water, stained in Gill's hematoxylin solution for 30 s, and washed several times in distilled water. After mounted with coverslips, the stained sections were observed under microscope and photographed.
###end p 39
###begin title 40
Supporting Information
###end title 40
###begin title 41
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
shRNA Expression and Knockdown of Sod2 Gene Expression in Line 26
###end title 41
###begin p 42
(A) Northern blots detect shRNA expression in transgene-positive line 26. Total RNA (30 mug) was loaded in each lane. The tissues are lung (1), heart (2), skeletal muscle (3), kidney (4), liver (5), brain (6), stomach (7), and spleen (8).
###end p 42
###begin p 43
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0020010-g002">Figure 2</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
(B) Western blots compare the SOD2 protein levels in the above tissues between line-26 mice and wild-type mice. + indicates transgene positive, and - indicates transgene negative. The amounts of proteins are loaded in the same order as described in Figure 2.
###end p 43
###begin p 44
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(C) SOD2 mRNA levels in the above tissues from transgenic line 26 measured by real-time PCR (n = 4). The levels were normalized to the level of SOD2 mRNA in tissues from the wild-type littermates, which were set as 100% (column C).
###end p 44
###begin p 45
(46 KB PDF)
###end p 45
###begin p 46
Click here for additional data file.
###end p 46
###begin title 47
Determining the Copy Number of the Transgene by Real-Time PCR
###end title 47
###begin p 48
(A) Testing the specificity of the primers used for real-time PCR. HEK293 cells were used as reference for gene copy number of ubiquitin C. NT, nontransgenic.
###end p 48
###begin p 49
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOD1</italic>
###xml 260 271 260 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubiquitin C</italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOD1</italic>
###xml 340 351 340 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubiquitin C</italic>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOD1</italic>
###xml 487 498 487 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin C</italic>
###xml 636 647 636 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin C</italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 820 831 820 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin C</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 536 541 <span type="species:ncbi:10090">mouse</span>
###xml 698 703 <span type="species:ncbi:9606">human</span>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
(B) Estimation of UbC-SOD2hp-EGFP gene copy numbers. A 118-bp segment in human ubiquitin C promoter was amplified using a pair of specific primers. Also amplified was human and mouse SOD1 gene using a pair of primers that are complementary to both genes. Both Ubiquitin C and SOD1 are single-copy genes. The threshold cycle number value of Ubiquitin C was normalized against the SOD1 detected in the same sample. The normalized value from HEK293 genomic DNA represents two copies of the ubiquitin C gene. By normalizing this value from mouse genomic DNA samples against the value from HEK293 cells, the estimates of copy numbers of the ubiquitin C transgene were obtained. The PCR primers used for human and mouse Sod1 gene were 5'-GACCTGGGCAATGTGACTGCTG-3' (forward) and 5'-CACCAGTGTACGGCCAATGATG-3' (reverse); and for ubiquitin C promoter were 5'-CGCTGCTCATAAGACTCGGC-3' (forward) and 5'-TTTCCTCGCCTGTTCCGCTC-3' (reverse). Bars are averages from four to six animals.
###end p 49
###begin p 50
(33 KB PDF)
###end p 50
###begin p 51
Click here for additional data file.
###end p 51
###begin title 52
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</italic>
Silencing Drosha Unblocked the Expression of EGFP Transgene in Muscle Fibroblasts
###end title 52
###begin p 53
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
(A) Drosha was knocked down by RNAi in the fibroblasts from wild-type and line-8 transgenic mice. The cells were transduced with adenoviral vectors expressing an shRNA against mouse Drosha (shRNA stem sequence: 5'-GGATGAAGATTTAGAGAGTTC-3'). Four days after transduction, the total RNA was extracted from the cells and used for RT-PCR to detect Drosha. The ribosomal RNA L17 was magnified in parallel as input control. The PCR was run for 28 cycles using the following primers for Drosha: 5'-GAGCCTAGAGGAAGCCAAACA-3' (forward) and 5'-GCCGGACGTGAGTGAAGAT-3' (reverse); for L17: 5'-CGGTATAATGGTGGAGTTG-3' (forward) and 5'-ACCCTTAAGTTCAGCGTTACT-3' (reverse).
###end p 53
###begin p 54
###xml 79 94 <span type="species:ncbi:10090">transgenic mice</span>
(B) No EGFP fluorescence could be detected in fibroblasts isolated from line-8 transgenic mice.
###end p 54
###begin p 55
(C) The same field as in (B) was stained with DAPI.
###end p 55
###begin p 56
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
(D) Three days after the fibroblasts were transduced with an adenoviral vector that expressed an shRNA against mouse Drosha, EGFP fluorescence was detected.
###end p 56
###begin p 57
(E) The same field as in (D) was stained with DAPI.
###end p 57
###begin p 58
(48 KB PDF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
We thank members of the Xu lab and Dr. Alonzo Ross for advice and support, Phillip Zamore for discussion and commenting on the manuscript, and Steve Jones and the University of Massachusetts Medical School transgenic core for pronuclear injection. This work was supported by grants from the Amyotrophic Lateral Sclerosis (ALS) Association, National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) (R01NS048145), NIH/National Institute on Aging (NIA) (R21AG023808), and The Robert Pachard Center for ALS Research at Johns Hopkins to ZX, and NIH/NIA (RO1AG18679) to SM. The contents of this report are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
###end p 60
###begin title 61
Abbreviations
###end title 61
###begin p 62
double-stranded RNA
###end p 62
###begin p 63
enhanced green fluorescent protein
###end p 63
###begin p 64
micro RNA
###end p 64
###begin p 65
RNA polymerase
###end p 65
###begin p 66
RNA-induced silencing complex
###end p 66
###begin p 67
RNA interference
###end p 67
###begin p 68
succinate dehydrogenase
###end p 68
###begin p 69
short hairpin RNA
###end p 69
###begin p 70
small interfering RNA
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
The knockout mouse project
###end article-title 72
###begin article-title 73
###xml 31 36 <span type="species:ncbi:9606">human</span>
Unlocking the potential of the human genome with RNA interference
###end article-title 73
###begin article-title 74
Revealing the world of RNA interference
###end article-title 74
###begin article-title 75
###xml 67 89 67 89 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 67 89 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
###end article-title 75
###begin article-title 76
Perspective: Machines for RNAi
###end article-title 76
###begin article-title 77
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action
###end article-title 77
###begin article-title 78
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
###end article-title 78
###begin article-title 79
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
###end article-title 79
###begin article-title 80
Mammalian RNAi for the masses
###end article-title 80
###begin article-title 81
Nuclear export of microRNA precursors
###end article-title 81
###begin article-title 82
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
###end article-title 82
###begin article-title 83
###xml 99 104 <span type="species:ncbi:9606">human</span>
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells
###end article-title 83
###begin article-title 84
An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi
###end article-title 84
###begin article-title 85
The nuclear RNase III Drosha initiates microRNA processing
###end article-title 85
###begin article-title 86
Processing of primary microRNAs by the Microprocessor complex
###end article-title 86
###begin article-title 87
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Specific interference with gene function by double-stranded RNA in early mouse development
###end article-title 87
###begin article-title 88
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Transgenic RNAi in mouse oocytes: A simple and fast approach to study gene function
###end article-title 88
###begin article-title 89
Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype
###end article-title 89
###begin article-title 90
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo
###end article-title 90
###begin article-title 91
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
###xml 64 68 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Small interfering RNA and gene silencing in transgenic mice and rats
###end article-title 91
###begin article-title 92
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
###end article-title 92
###begin article-title 93
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Germline transmission of RNAi in mice
###end article-title 93
###begin article-title 94
###xml 39 43 <span type="species:ncbi:10090">mice</span>
A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA
###end article-title 94
###begin article-title 95
Cre-lox-regulated conditional RNA interference from transgenes
###end article-title 95
###begin article-title 96
Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown
###end article-title 96
###begin article-title 97
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
###end article-title 97
###begin article-title 98
Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases. Neurodegenerative Dis 2: In press
###end article-title 98
###begin article-title 99
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Single copy shRNA configuration for ubiquitous gene knockdown in mice
###end article-title 99
###begin article-title 100
###xml 63 68 <span type="species:ncbi:9606">human</span>
Sequence requirements for micro RNA processing and function in human cells
###end article-title 100
###begin article-title 101
siRNA-mediated gene silencing in vitro and in vivo
###end article-title 101
###begin article-title 102
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 29 34 <span type="species:ncbi:9606">human</span>
New microRNAs from mouse and human
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs
###end article-title 103
###begin article-title 104
Trans-splicing and polyadenylation of let-7 microRNA primary transcripts
###end article-title 104
###begin article-title 105
MicroRNA genes are transcribed by RNA polymerase II
###end article-title 105
###begin article-title 106
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
###end article-title 106
###begin article-title 107
###xml 33 37 <span type="species:ncbi:10090">mice</span>
The use of transgenic and mutant mice to study oxygen free radical metabolism
###end article-title 107
###begin article-title 108
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Mitochondrial disease in superoxide dismutase 2 mutant mice
###end article-title 108
###begin article-title 109
###xml 185 189 <span type="species:ncbi:10090">mice</span>
Endogenous mitochondrial oxidative stress: Neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice
###end article-title 109
###begin article-title 110
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
###end article-title 110
###begin article-title 111
Induction of an interferon response by RNAi vectors in mammalian cells
###end article-title 111
###begin article-title 112
Determinants of interferon-stimulated gene induction by RNAi vectors
###end article-title 112
###begin article-title 113
Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology
###end article-title 113
###begin article-title 114
Conditional transgenic technologies
###end article-title 114
###begin article-title 115
###xml 3 7 <span type="species:ncbi:10090">mice</span>
Of mice and models: Improved animal models for biomedical research
###end article-title 115
###begin article-title 116
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
###end article-title 116
###begin article-title 117
APC dosage effects in tumorigenesis and stem cell differentiation
###end article-title 117
###begin article-title 118
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 69 75 <span type="species:ncbi:9606">humans</span>
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
###end article-title 118
###begin article-title 119
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Postischemic recovery of contractile function is impaired in SOD2+/- but not SOD1+/- mouse hearts
###end article-title 119
###begin article-title 120
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Muscle satellite cells from dystrophic (mdx) mice have elevated levels of heparan sulphate proteoglycan receptors for fibroblast growth factor
###end article-title 120
###begin title 121
Figures and Tables
###end title 121
###begin title 122
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
shRNA Expression and Knockdown of Sod2 Gene Expression In Vivo
###end title 122
###begin p 123
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0020010-b013">13</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
(A) Schematic illustration of the transgene construct. The shRNA was designed to mimic human miR-30a structure (for details, see [13]).
###end p 123
###begin p 124
(B) PCR analysis of tail DNA identified transgenic founders. C+ indicates positive control; C-, negative control. Numbers indicate examples of various transgenic lines.
###end p 124
###begin p 125
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
(C) Northern blots detected shRNA expression in transgene-positive line-8 mice, but not in line-60 mice. Total RNA (30 mug) was loaded in each lane. The tissues are lung (1), heart (2), skeletal muscle (3), kidney (4), liver (5), brain (6), stomach (7), and spleen (8). C+ is the siRNA-positive control.
###end p 125
###begin p 126
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
(D) Western blots of SOD2 protein compare the SOD2 levels in the above tissues between line-8 mice and wild-type mice. Due to different levels of SOD2 in different tissues, different amounts of total protein from different tissues had to be loaded in order to maintain the assay in linear range. The amounts of proteins are the following in micrograms: (1) 30; (2-4) 10; (5-6) 15; (7) 20; and (8) 40. + indicates transgene positive; -, transgene negative.
###end p 126
###begin p 127
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
(E) SOD2 mRNA levels in the above tissues from transgenic line-8 mice measured by real-time PCR (n = 4; all "n" indicates mouse numbers). The levels were normalized to the level of SOD2 mRNA in tissues from the wild-type littermates, which were set as 100% (column C).
###end p 127
###begin p 128
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
(F) Levels of SOD2 activity in tissue lysates of transgenic line-8 mice compared with the wild-type littermates (n = 4).
###end p 128
###begin title 129
Consequence of the SOD2 Knockdown
###end title 129
###begin p 130
###xml 87 91 <span type="species:ncbi:10090">mice</span>
(A) Histochemical staining reveals that SDH activity in the heart of transgenic line-8 mice was reduced compared with the wild-type littermates (B).
###end p 130
###begin p 131
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
(C) ROS levels are increased in fibroblasts from the skeletal muscles of transgenic line-26 (top panel) and line-8 (bottom panel) mice, compared with those from the wild-type mice (middle panel). AU, arbitrary units.
###end p 131
###begin p 132
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
(D) Fibroblasts from the transgenic line-8 mice have elevated sensitivity to oxidative stress compared with those from the wild-type mice, and this sensitivity can be corrected by expressing an RNAi-resistant SOD2 (line 8 + SOD2r). The data are means observed in cells isolated from four individual mice. Error bars are SEM. The asterisks indicate significant difference as compared to either WT or rescued cells (p < 0.05).
###end p 132
###begin p 133
###xml 133 137 <span type="species:ncbi:10090">mice</span>
(E) Western blot detects SOD2 protein levels in fibroblasts isolated from the skeletal muscle of the wild-type and transgenic line-8 mice. The third lane is from the line-8 cells transduced with RAd expressing the siRNA-resistant SOD2.
###end p 133
###begin title 134
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
The Level of SOD2 Expression Was Knocked Down Further in Bigenic Transgenic Mice Generated by Crossing the Two Lines (Lines 8 and 26)
###end title 134
###begin p 135
###xml 88 92 <span type="species:ncbi:10090">mice</span>
(A) Northern blots indicate that siRNA levels are further increased in the 8/26 bigenic mice.
###end p 135
###begin p 136
###xml 100 104 <span type="species:ncbi:10090">mice</span>
(B) Western blots demonstrate that SOD2 protein levels are further knocked down in the 8/26 bigenic mice.
###end p 136
###begin p 137
###xml 86 90 <span type="species:ncbi:10090">mice</span>
(C) Real-time PCR shows that SOD2 mRNA levels are further lowered in the 8/26 bigenic mice.
###end p 137
###begin title 138
###xml 17 21 <span type="species:ncbi:10090">Mice</span>
The 8/26 Bigenic Mice Display the Phenotype of a SOD2-Null Animal
###end title 138
###begin p 139
(A) Retarded growth (7-d-old animals).
###end p 139
###begin p 140
(B) Dilated cardiomyopathy (H&E-stained coronal sections of heart). LV, left ventricle; RV, right ventricle.
###end p 140
###begin p 141
(C-F) Lipid deposition in heart (C and D) and liver (E and F) stained with Oil Red O.
###end p 141
###begin title 142
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OSA1</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
In Vivo Expression of SOD2 shRNA with Authentic miR30a Structure Did Not Up-Regulate the Expression of OSA1 and STAT1
###end title 142
###begin p 143
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OAS1</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT1</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
Levels of the mRNAs were determined by real-time PCR. The levels of OAS1 and STAT1 mRNAs in the shRNA transgenic tissues from line-8 mice were normalized to GAPDH mRNA and expressed relative to that of wild-type littermate tissues. Data represent means from four mice + SEM.
###end p 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. XGX, HZ, and ZX conceived and designed the experiments. XGX, HZ, ES, and SM performed the experiments. XGX, HZ, ES, SM, and ZX analyzed the data. XGX, HZ, ES, and SM contributed reagents/materials/analysis tools. ZX wrote the paper.
###end p 144
###begin p 145
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. XGX, HZ, and ZX are authors of a pending patent on the Pol II-shRNA construct used in this study.
###end p 145
###begin p 146
A previous version of this article appeared as an Early Online Release on December 14, 2005 (DOI: ).
###end p 146
###begin p 147
###xml 159 163 <span type="species:ncbi:10090">mice</span>
Citation: Xia XG, Zhou H, Samper E, Melov S, Xu Z (2006) Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2(1): e10.
###end p 147

